
Adam Leventhal, PhDopens in new window, a professor of preventive medicine and psychology at the University of Southern California (USC) in Los Angeles, and executive director of USC’s Institute for Addiction Scienceopens in new window (IAS), specializes in policy-oriented research in the complex, high-stakes field of addiction. A clinical psychologist, he is an APA fellow in three divisions —Division 12 (Society of Clinical Psychology); Division 28 (Society for Psychopharmacology and Substance Use); and Division 50 (Society of Addiction Psychology)—and the recipient, in 2022, of the American Psychological Foundation’s Gold Medal Award for Impact in Psychology.
Leventhal has helped assemble, in the IAS, the country’s first university-wide, interdisciplinary team charged with addressing addiction epidemics like the ongoing opioid crisis, which claimed the lives of 565,000 Americans who died of overdosesopens in new window of powerful pain medications derived from opium, or its synthetic versions, between 1999 and 2020. The IAS comprises 80 faculty members across 10 USC schools and colleges, and provides an infrastructure for research, education, and community engagement.
When you take down the silos that separate various academic disciplines, “addiction science is an all-hands-on-deck approach,” Leventhal says.
Opioids epitomize addiction’s potential for damage. Along with tobaccoopens in new window and alcoholopens in new window, which also cause hundreds of thousands of deaths each year in the United States, opioids are somewhat on the decline these days, in part thanks to intensive educational campaignsopens in new window to inform the public about their potential harmopens in new window. However, more young people are now using cannabis, hallucinogensopens in new window and new nicotine products. Social mediaopens in new window, which didn’t exist 30 years ago, is proving to be addictive and sometimes harmful as well.
Perhaps half of humans are addicted to somethingopens in new window, including gambling, sex, exercise, shopping, or their jobs, Leventhal’s USC colleague Steven Sussmanopens in new window has shown, and it’s devilishly hard to disrupt those dependencies.
From a public health perspective, “I don’t think addiction will ever be eradicated,” Leventhal says. “People have an inherent drive to feel good.”
There is “some promising data” for the ability of GLP-1 (Glucagon-like peptide-1) agonist drugs like Ozempicopens in new window and Wegovyopens in new window, now used for diabetes, weight loss, and other conditions, to curb addictive behavior, Leventhal says, but he adds that the science around GLP-1 drugs to treat addiction is in its infancy.
Addiction is extremely lucrative, as the opioid crisisopens in new window has shown. In addition to legal products, there are others provided by unfettered criminal enterprises, like heroin, cocaine, and illicitly distributed oxycodone and fentanyl, a synthetic opioid.
“The commercial and illegal markets that supply addictive agents move much faster than science,” Leventhal says. “If we don’t do something different, this gap between addiction science and practice is only going to grow.”
In defining addictionopens in new window, the “key piece is paradoxical behavior,” Leventhal says—consuming a substance or engaging in an activity that has negative consequences the addicted person recognizes and does not want to continue, but does. Addictive behaviors are initially pleasurable, and “are characterized by unusually powerful reinforcers, often because they are engineered to be,” Leventhal says.

